Ultragenyx Pharmaceutical | RARE - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Immunic 0 0 2025-03
Insmed USD 256.46M 38.78M 2026-03
Ionis Pharmaceuticals USD 243M 48M 2026-03
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Kyowa Hakko Kirin JPY 88.25B 21.26B 2026-03
MacroGenics USD 31.11M 30.14M 2025-12
Moderna USD -566M 792M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
Ultragenyx Pharmaceutical USD 106M 72M 2026-03
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03
Xoma 992K 846K 2024-06